Flüssige und Verdampfbare Zusammensetzung mit Cannabinoid(en) zur Therapeutischen Verwendung
EP4796105
26. August 2026
Anmelder: Versevrage 🇫🇷
Details
- Veröffentlichungs-Nr.
- EP4796105
- Anmeldetag
- 25. Februar 2025
- Veröffentlichung
- 26. August 2026
- Rechtsraum
- EP
Abstract
The present invention relates to a liquid and vaporizable composition comprising: (1) a distillate of at least one cannabinoid selected from THC, CBD and their mixtures thereof wherein the distillate comprises less than 1% by weight of terpene, based on the total weight of distillate, (2) and at least one diol selected from 1,2-propanediol 1,3-propanediol, 1,3-butanediol, 1,4-butanediol, 2-methyl-1,3-propanediol, polyethylene glycol (PEG), polyethylene glycol 400 (PEG 400), and mixtures thereof. The composition is used as a medicament wherein a constant dose of cannabinoid(s) is delivered to a subject in need through a vaporizing device.
Anmelder
- Firma
- Versevrage
- Land
- 🇫🇷 Frankreich